TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Turnover |
28,871
|
27,868
|
27,570 |
| Financial expenses |
1,404
|
376
|
7 |
| Earnings before taxes |
12,723
|
14,557
|
15,734 |
| EBITDA |
14,670
|
15,035
|
16,307 |
| Total assets |
66,532
|
67,217
|
57,165 |
| Current assets |
39,683
|
41,321
|
29,754 |
| Current liabilities |
10,026
|
10,539
|
4,416 |
| Equity capital |
55,700
|
55,966
|
52,070 |
| - share capital |
59
|
56
|
57 |
| Employees (average) |
93
|
89
|
86 |
Financial ratios
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Solvency |
83.7%
|
83.3%
|
91.1% |
| Turnover per employee |
310
|
313
|
321 |
| Profit as a percentage of turnover |
44.1%
|
52.2%
|
57.1% |
| Return on assets (ROA) |
21.2%
|
22.2%
|
27.5% |
| Current ratio |
395.8%
|
392.1%
|
673.8% |
| Return on equity (ROE) |
22.8%
|
26.0%
|
30.2% |
| Change turnover |
-733
|
894
|
4,057 |
| Change turnover % |
-2%
|
3%
|
17% |
| Chg. No. of employees |
4
|
3
|
11 |
| Chg. No. of employees % |
4%
|
3%
|
15% |
Total value of public sale
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.